Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bailong tablet and chemotherapy in the treatment of moderate and advanced cancersand chemotherapy in the treatment of moderate and advanced cancers

  • 13 Accesses

Abstract

Objective: To determine the effectiveness of Bailong Tablet

and chemotherapy on treatment of moderate and advanced cancers.Methods: The patients were divided randomly into two groups. The treated group (n= 41) was treated with chemotherapy plus Bailong Tablet; and the control group (n= 22) treated with chemotherapy alone. Treatment effectiveness was measured with Karnofsky scores.Results: Karnofsky performance status in the treated group before and after treatment was 66.0 ± 8.7 and 68.0 ± 5.9 respectively, that in the control group was 67. 0 ± 6.8 and 53. 0 ± 7.3 respectively. The completion rate of chemotherapy in the treated group (92.6%, 38/41) was higher than that in control (77.2%, 17/22,P < 0.05). The side-effects caused by chemotherapy in the treated group were lower than that in the control group (P < 0.05). CD3 +, CD4 + and CD4 + /CD8 + ratio were higher in the treated group.Conclusion: Bailong Tablet can enhance the therapeutic effect and reduce the side-effects of chemotherapy. One possible mechanism is the modulation of cellular immune function.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    1990: 2 1–14, 4 14–50, 6 1–3, 15.

  2. 2.

    1, 1995:485–507.

  3. 3.

    A 1997; 16(4):246.

  4. 4.

    1994; 14 :302.

Download references

Author information

Correspondence to Xinqi Zhang or Shujun Liu or Yunyan Liang or Xinduo Liu or Daishu Wang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, X., Liu, S., Liang, Y. et al. Bailong tablet and chemotherapy in the treatment of moderate and advanced cancersand chemotherapy in the treatment of moderate and advanced cancers. CJIM 4, 175–177 (1998). https://doi.org/10.1007/BF02934053

Download citation

Key Words

  • malignant tumor
  • chemotherapy
  • Bailong Tablet
  • T lymphocyte subset